A study suggests, for the first time, one reason why two promising trials designed to investigate therapies for acute respiratory distress syndrome were halted for futility.
The University of Alabama at Birmingham has been awarded a $28 million grant renewal for the nation’s largest study aimed at exploring racial and geographic differences in stroke illness and stroke death from The National Institute for Neurological Disorders and Stroke.
New research co-authored by a University of Alabama at Birmingham researcher has shown that intensive lifestyle interventions, including diet and exercise, have the potential to put Type 2 diabetes into remission and eliminate the need for medication in some cases.
The approach will examine an interactive “direct-to-participant” method using new technology, including an iPad app, in a study supported by the Agency for Healthcare Research and Quality.
Using a motion-sensing chip built into a wristwatch-shaped device, sleep scientists can build a highly accurate map of a person’s daily cycle of sleep and wakefulness.
Most of this disparity may be due to greater risk factor burden among blacks, including smoking, diabetes and hypertension.
UAB researchers have identified a set of experimental drugs called LRRK2 inhibitors that may go beyond symptom relief to directly counter the inflammation and nerve cell death at the root of Parkinson’s disease.
Faculty members recognized for their outstanding contributions to the School of Medicine.
Genetic changes that protected their ancestors against fly-borne parasites may partly explain why African-Americans with lupus are up to five times more likely to develop end-stage kidney disease than those of European descent. This was the conclusion of a study presented this week at the American College of Rheumatology Scientific Sessions in Washington, D.C.
Severe sepsis strikes about 750,000 Americans each year, most of them older and often ill, with as many as half of these patients dying as septic shock shuts down their organs